Dasari A, Shen C, Halperin D, Zhao B, Zhou S, Xu Y, et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol. 2017;3(10):1335–42.
PubMed PubMed Central Google Scholar
Borbath I, Garcia-Carbonero R, Bikmukhametov D, Jimenez-Fonseca P, Castaño A, Barkmanova J, et al. The European neuroendocrine tumour society registry, a tool to assess the prognosis of neuroendocrine neoplasms. Eur J Cancer. 2022;168:80–90.
Howe JR, Cardona K, Fraker DL, Kebebew E, Untch BR, Wang YZ, et al. The surgical management of small bowel neuroendocrine tumors: consensus guidelines of the north american neuroendocrine tumor society. Pancreas. 2017;46(6):715–31.
PubMed PubMed Central Google Scholar
Howe JR, Merchant NB, Conrad C, Keutgen XM, Hallet J, Drebin JA, et al. The North American neuroendocrine tumor society consensus paper on the surgical management of pancreatic neuroendocrine tumors. Pancreas. 2020;49(1):1–33.
PubMed PubMed Central Google Scholar
Kos-Kudła B, Castaño JP, Denecke T, Grande E, Kjaer A, Koumarianou A, et al. European neuroendocrine tumour society (ENETS) 2023 guidance paper for nonfunctioning pancreatic neuroendocrine tumours. J Neuroendocrinol. 2023;35(12):e13343.
Hofland J, Falconi M, Christ E, Castaño JP, Faggiano A, Lamarca A, et al. European neuroendocrine tumor society 2023 guidance paper for functioning pancreatic neuroendocrine tumour syndromes. J Neuroendocrinol. 2023;35(8):e13318.
Lamarca A, Bartsch DK, Caplin M, Kos-Kudla B, Kjaer A, Partelli S, et al. European neuroendocrine tumor society (ENETS) 2024 guidance paper for the management of well-differentiated small intestine neuroendocrine tumours. J Neuroendocrinol. 2024;36(9):e13423.
Kaltsas G, Walter T, Knigge U, Toumpanakis C, Santos AP, Begum N, et al. European neuroendocrine tumor society (ENETS) 2023 guidance paper for appendiceal neuroendocrine tumours (aNET). J Neuroendocrinol. 2023;35(10):e13332.
Rinke A, Ambrosini V, Dromain C, Garcia-Carbonero R, Haji A, Koumarianou A, et al. European neuroendocrine tumor society (ENETS) 2023 guidance paper for colorectal neuroendocrine tumours. J Neuroendocrinol. 2023;35(6):e13309.
Panzuto F, Ramage J, Pritchard DM, van Velthuysen M-LF, Schrader J, Begum N, et al. European neuroendocrine tumor society (ENETS) 2023 guidance paper for gastroduodenal neuroendocrine tumours (NETs) G1–G3. J Neuroendocrinol. 2023;35(8):e13306.
Albers MB, Almquist M, Bergenfelz A, Nordenström E. Complications of surgery for gastro-entero-pancreatic neuroendocrine neoplasias. Langenbeck’s Archives Surg. 2020;405(2):137–43.
Partelli S, Bartsch DK, Capdevila J, Chen J, Knigge U, Niederle B, et al. ENETS consensus guidelines for standard of care in neuroendocrine tumours: surgery for small intestinal and pancreatic neuroendocrine tumours. Neuroendocrinology. 2017;105(3):255–65.
Assi HA, Mukherjee S, Kunz PL, Machiorlatti M, Vesely S, Pareek V, et al. Surgery versus surveillance for well-differentiated, nonfunctional pancreatic neuroendocrine tumors: an 11-year analysis of the national cancer database. Oncologist. 2020;25(2):e276-83.
Partelli S, Massironi S, Zerbi A, Niccoli P, Kwon W, Landoni L, et al. Management of asymptomatic sporadic non-functioning pancreatic neuroendocrine neoplasms no larger than 2 cm: interim analysis of prospective ASPEN trial. Br J Surg. 2022;109(12):1186–90.
PubMed PubMed Central Google Scholar
Heidsma CM, Engelsman AF, van Dieren S, Stommel MWJ, de Hingh I, Vriens M, et al. Watchful waiting for small non-functional pancreatic neuroendocrine tumours: nationwide prospective cohort study (PANDORA). Br J Surg. 2021;108(8):888–91.
CAS PubMed PubMed Central Google Scholar
Chivukula SV, Tierney JF, Hertl M, Poirier J, Keutgen XM. Operative resection in early stage pancreatic neuroendocrine tumors in the United States: are we over- or undertreating patients? Surgery. 2020;167(1):180–6.
Nießen A, Bechtiger FA, Hinz U, Lewosinska M, Billmann F, Hackert T, et al. Enucleation is a feasible procedure for well-differentiated pNEN-A matched pair analysis. Cancers (Basel). 2022;14(10).
Mehrabi A, Fischer L, Hafezi M, Dirlewanger A, Grenacher L, Diener MK, et al. A systematic review of localization, surgical treatment options, and outcome of insulinoma. Pancreas. 2014;43(5):675–86.
de Carbonnières A, Challine A, Cottereau AS, Coriat R, Soyer P, Abou Ali E, et al. Surgical management of insulinoma over three decades. HPB (Oxford). 2021;23(12):1799–806.
Beane JD, Borrebach JD, Billderback A, Onuma AE, Adam MA, Zureikat AH, et al. Small pancreatic neuroendocrine tumors: resect or enucleate? Am J Surg. 2021;222(1):29–34.
Hüttner FJ, Koessler-Ebs J, Hackert T, Ulrich A, Büchler MW, Diener MK. Meta-analysis of surgical outcome after enucleation versus standard resection for pancreatic neoplasms. Br J Surg. 2015;102(9):1026–36.
Zhou Y, Zhao M, Wu L, Ye F, Si X. Short- and long-term outcomes after enucleation of pancreatic tumors: an evidence-based assessment. Pancreatology. 2016;16(6):1092–8.
Nießen A, Schimmack S, Lewosinska M, Hinz U, Bechtiger FA, Hackert T, et al. Lymph node metastases and recurrence in pancreatic neuroendocrine neoplasms. Surgery. 2022;172(6):1791–9.
Zhang Z, Liu M, Ji S, Luo G, Xu W, Liu W, et al. Prognostic value and clinical predictors of Lymph Node metastases in pancreatic neuroendocrine tumors. Pancreas. 2020;49(3):381–6.
Partelli S, Gaujoux S, Boninsegna L, Cherif R, Crippa S, Couvelard A, et al. Pattern and clinical predictors of lymph node involvement in nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs). JAMA Surg. 2013;148(10):932–9.
Bilimoria KY, Talamonti MS, Tomlinson JS, Stewart AK, Winchester DP, Ko CY, et al. Prognostic score predicting survival after resection of pancreatic neuroendocrine tumors: analysis of 3851 patients. Ann Surg. 2008;247(3):490–500.
Conrad C, Kutlu OC, Dasari A, Chan JA, Vauthey J-N, Adams DB, et al. Prognostic value of Lymph Node Status and Extent of Lymphadenectomy in pancreatic neuroendocrine tumors confined to and extending beyond the pancreas. J Gastrointest Surg. 2016;20(12):1966–74.
Giulianotti PC, Coratti A, Angelini M, Sbrana F, Cecconi S, Balestracci T, et al. Robotics in general surgery: personal experience in a large community hospital. Arch Surg. 2003;138(7):777–84.
Joyce D, Morris-Stiff G, Falk GA, El-Hayek K, Chalikonda S, Walsh RM. Robotic surgery of the pancreas. World J Gastroenterol. 2014;20(40):14726–32.
PubMed PubMed Central Google Scholar
Klotz R, Mihaljevic AL, Kulu Y, Sander A, Klose C, Behnisch R, et al. Robotic versus open partial pancreatoduodenectomy (EUROPA): a randomised controlled stage 2b trial. Lancet Reg Health Eur. 2024;39:100864.
PubMed PubMed Central Google Scholar
de Rooij T, van Hilst J, van Santvoort H, Boerma D, van den Boezem P, Daams F, et al. Minimally invasive Versus Open Distal pancreatectomy (LEOPARD): a Multicenter patient-blinded Randomized Controlled Trial. Ann Surg. 2019;269(1):2–9.
Korrel M, Jones LR, van Hilst J, Balzano G, Björnsson B, Boggi U, et al. Minimally invasive versus open distal pancreatectomy for resectable pancreatic cancer (DIPLOMA): an international randomised non-inferiority trial. Lancet Reg Health Eur. 2023;31:100673.
PubMed PubMed Central Google Scholar
Li P, Zhang H, Chen L, Liu T, Dai M. Robotic versus laparoscopic distal pancreatectomy on perioperative outcomes: a systematic review and meta-analysis. Updates Surg. 2023;75(1):7–21.
Partelli S, Andreasi V, Rancoita PMV, Perez-Sanchez E, Muffatti F, Balzano G, et al. Outcomes after distal pancreatectomy for neuroendocrine neoplasms: a retrospective comparison between minimally invasive and open approach using propensity score weighting. Surg Endosc. 2021;35(1):165–73.
Zheng J, Pulvirenti A, Javed AA, Michelakos T, Paniccia A, Lee KK, et al. J Am Coll Surg. 2022;235(2):315–30.
Pavone M, Seeliger B, Teodorico E, Goglia M, Taliento C, Bizzarri N, et al. Ultrasound-guided robotic surgical procedures: a systematic review. Surg Endosc. 2024;38(5):2359–70.
PubMed PubMed Central Google Scholar
Paiella S, De Pastena M, Landoni L, Esposito A, Casetti L, Miotto M, et al. Is there a role for near-infrared technology in laparoscopic resection of pancreatic neuroendocrine tumors? Results of the COLPAN colour-and-resect the pancreas study. Surg Endosc. 2017;31(11):4478–84.
Wei K, Zheng Q, Cheng L, li W, Nießen A, Uzunoglu FG, et al. Minimally invasive versus open surgery for non-functioning pancreatic neuroendocrine tumors: a systematic review and meta-analysis. Int J Surg. 2024. https://doi.org/10.1097/JS9.0000000000002143.
Article PubMed PubMed Central Google Scholar
Bockhorn M, Uzunoglu FG, Adham M, Imrie C, Milicevic M, Sandberg AA, et al. Borderline resectable pancreatic cancer: a consensus statement by the International Study Group of pancreatic surgery (ISGPS). Surgery. 2014;155(6):977–88.
Hackert T, Klaiber U, Pausch T, Mihaljevic AL, Büchler MW. Fifty years of surgery for pancreatic Cancer. Pancreas. 2020;49(8):1005–13.
Comments (0)